Insulin‐like growth factor‐I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45

Hua Li(Fujian University of Traditional Chinese Medicine), Yasuhisa Shinomura(Sapporo Medical University)
Cancer
January 24, 2011
Cited by 43


Related Papers